FDA approves Novo Nordisk diabetes drug Ozempic

16

(Reuters) – The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli Lilly & Co's Trulicity.
Source : http://in.reuters.com/